fda warning letters compounded semaglutide tirzepatide 2024 2025 Troubling Findings in Study of GLP-1 Compounders September 15, 2025: Telehealth company

2 Data from the largest clinical trial of GLP-1s to date (the SELECT trial of nearly 18,000 participants) showed in November 2023 that Wegovy (Novo Nordisks GLP-1 for weight loss) reduced heart attacks, strokes and deaths due to cardiovascular disease and 73% fewer patients progressed to diabetes vs

Formulations are made by nationwide compounding pharmacies specializing in wellness, anti-aging, weight management, sexual wellness, aesthetic dermatology and thyroid and adrenal health

Monthly Kit: Includes 4 needles and 4 swabs to serve as a standalone, clean-room kit for one full month of metabolic transformation

Two people start the same medication